London Institute of Cancer Research: Clinical Trial Design Could Improve Dose Selection, Maximising Treatment Efficacy and Safety
June 29, 2026
June 29, 2026
LONDON, England, June 29 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
New clinical trial design could improve dose selection, maximising treatment efficacy and safety
Researchers have developed a new approach to help determine the optimal dose of cancer drugs, aiming to make early-stage clinical trials more transparent and better aligned with patient needs.
Led by The Institute of Cancer Research, London, the st . . .
* * *
New clinical trial design could improve dose selection, maximising treatment efficacy and safety
Researchers have developed a new approach to help determine the optimal dose of cancer drugs, aiming to make early-stage clinical trials more transparent and better aligned with patient needs.
Led by The Institute of Cancer Research, London, the st . . .